Citation

King A. Nat. Rev. Cardiol. 2010; 7(11): e602.

Copyright

(Copyright © 2010, Holtzbrinck Springer Nature Publishing Group)

DOI

10.1038/nrcardio.2010.148

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; depression; clinical trial; risk assessment; treatment outcome; obesity; article; mental disease; controlled study; triacylglycerol; priority journal; atherosclerosis; anxiety disorder; gastrointestinal symptom; placebo; risk benefit analysis; low density lipoprotein cholesterol; cardiovascular disease; neurologic disease; high density lipoprotein cholesterol; treatment response; triacylglycerol blood level; cannabinoid 1 receptor; rimonabant